Tratamiento con midostaurina de leucemia mieloide aguda con mutacin en FLT 3 en Mxico: los retos en un pas en desarrollo

Por lo tanto, en base a su perfil de eficacia y seguridad, ofatumumab debe considerarse una alternativa de tratamiento para pacientes con EMRR o EMSP con enfermedad activa

The aim of this study was to evaluate the postoperative results in patients >75 years old with ankle fractures treated by ORIF (open reduction and internal fixation) or MIPO,

Absence of the wild- type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer

(2013a) Nonequivalent gene expression and copy number alterations in high-grade serous ovarian cancers with BRCA1 and BRCA2 mutations. (2013b) Nonequivalent Gene

The World Dental Federation, the World Health Organization (WHO), and the International Association for Dental Research have proposed goals for tooth loss for the year 2020: (3)

(Averaged age at first de- livery in women with unfinished primary studies equals.. 23.4 years vs 29.8 in women with high education; aver- aged age in women with low occupational

pared with older‐age individuals [25–27]. For example, emerging (18–24 years old) and 

IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with